Eisai
4523.T
$37.46
Share price
0.84%
Change (1 day)
-30.18%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
Market capitalization of Eisai (4523.T)
Market cap: S$10.56 Billion
As of April 2025 Eisai has a market cap of S$10.56 Billion. This makes Eisai the world's 1955th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Eisai from 2000 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | S$10.56 B | -0.04% |
| 2024 | S$10.57 B | -44.19% |
| 2023 | S$18.94 B | -24.31% |
| 2022 | S$25.02 B | 13.76% |
| 2021 | S$21.99 B | -18.84% |
| 2020 | S$27.10 B | -6.87% |
| 2019 | S$29.10 B | -3.43% |
| 2018 | S$30.13 B | 38.56% |
| 2017 | S$21.74 B | -8.91% |
| 2016 | S$23.87 B | -11.71% |
| 2015 | S$27.04 B | 83.46% |
| 2014 | S$14.74 B | 5.09% |
| 2013 | S$14.02 B | -3.89% |
| 2012 | S$14.59 B | -3.57% |
| 2011 | S$15.13 B | 14.28% |
| 2010 | S$13.24 B | -10.05% |
| 2009 | S$14.72 B | -14.95% |
| 2008 | S$17.31 B | 2.93% |
| 2007 | S$16.81 B | -30.2% |
| 2006 | S$24.09 B | 20.69% |
| 2005 | S$19.96 B | 29.35% |
| 2004 | S$15.43 B | 13.83% |
| 2003 | S$13.55 B | 19.3% |
| 2002 | S$11.36 B | -16.36% |
| 2001 | S$13.58 B | -24.38% |
| 2000 | S$17.96 B |
End of Day market cap according to different sources
On Apr 22nd, 2025 the market cap of Eisai was reported to be:
S$10.58 Billion
S$10.58 Billion